Company news
Invivyd, Inc. news in 2022
Invivyd, Inc.'s news releases, calls and decks from 2022, newest first.
Invivyd Appoints Jeremy Gowler as Chief Operating and Commercial Officer, Promotes Pete Schmidt, M.D., to Chief Medical Officer
December 5, 2022
Invivyd Announces Partnership With Population Health Partners to Accelerate Clinical Development in Infectious Diseases Including COVID-19
November 16, 2022
Invivyd Reports Third Quarter 2022 Financial Results and Business Highlights
November 9, 2022
Invivyd to Host Conference Call on November 10 to Discuss Third Quarter 2022 Financial Results and Recent Business Highlights
November 1, 2022
Invivyd Announces the Appointment of Christine Lindenboom to Board of Directors
October 23, 2022
Invivyd Appoints Fred Driscoll as Interim Chief Financial Officer and Announces Resource Reallocation to Maximize Integrated Discovery Platform
October 12, 2022
Invivyd to Present Multiple Posters Highlighting Clinical Data from Adintrevimab During ID Week 2022
October 11, 2022
Invivyd Announces Multiple Next Generation COVID-19 Antibody Candidates and Selects Combination for Clinical Advancement Based on Positive in vitro Data Against Omicron Variants
September 11, 2022
Calls in 2022
Decks in 2022
- Adagio Therapeutics — Investor Presentation (September 2022)
Investor deck · 27 slides · Sep 12, 2022
- Technical Presentation (April 2022)
Technical · 4 slides · April 2022
- Technical Presentation (2022)
Technical · 4 slides · 2022